47 results
DEFM14A
SQZB
SQZ Biotechnologies Co
23 Jan 24
Proxy related to merger
4:31pm
and satisfaction of liabilities and commitments in the ordinary course of business.
Impact of the COVID-19 Pandemic
In December 2019, a novel strain … of the pandemic and its effects on the Company’s business and operations are uncertain.
The COVID-19 pandemic has impacted and may continue to impact
PREM14A
SQZB
SQZ Biotechnologies Co
12 Jan 24
Preliminary proxy related to merger
8:57am
the realization of assets and satisfaction of liabilities and commitments in the ordinary course of business.
Impact of the COVID-19 Pandemic
In December 2019 … . The future progression of the pandemic and its effects on the Company’s business and operations are uncertain.
The COVID-19 pandemic has impacted
8-K
SQZB
SQZ Biotechnologies Co
15 Jun 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:37pm
-19 pandemic on the Company’s operations and clinical activities; the Company’s need for additional funding and its cash runway; the lengthy, expensive
8-K
EX-99.1
7aiw55eyj3f p5
6 Dec 22
Designation Represents Potential to Bring Important New Therapy to Patients Earlier
4:23pm
8-K
6bbqbtj 2zydo9qn182o
6 Dec 22
Designation Represents Potential to Bring Important New Therapy to Patients Earlier
4:23pm
8-K
kdhu5xu1nz7rlf59
30 Nov 22
Cost Associated with Exit or Disposal Activities
4:32pm
8-K
EX-99.1
767s23tp 6zc9
30 Nov 22
Cost Associated with Exit or Disposal Activities
4:32pm
8-K
EX-99.1
hpk5sr
6 Sep 22
SQZ Biotechnologies Announces Leadership Transition
4:33pm
8-K
EX-99.1
fsf4fhu5iq 32z2qeypx
11 Jul 22
SQZ Biotechnologies Appoints Micah Zajic as Chief Financial Officer
4:49pm
8-K
EX-99.1
vmsbfv 2sawx2ozn3
31 May 22
Experienced Drug Developer Brings Over 25 Years of Clinical Development Industry Knowledge Across Oncology, Immunology, and Infectious Disease
4:52pm
8-K
398si q07n1
24 Jan 22
SQZ Biotechnologies Announces FDA Clearance of Investigational New Drug (IND) Application for SQZ-eAPC-HPV, a Novel mRNA-based Cell Therapy for the Treatment of HPV16 Positive Solid Tumors
7:01am
8-K
EX-99.1
f6lpv ohifxhqlz
24 Jan 22
SQZ Biotechnologies Announces FDA Clearance of Investigational New Drug (IND) Application for SQZ-eAPC-HPV, a Novel mRNA-based Cell Therapy for the Treatment of HPV16 Positive Solid Tumors
7:01am
8-K
EX-99.3
lkrnljiko21x
9 Dec 21
Other Events
7:30am